Sylvester Comprehensive Cancer Center Hosts Cancer Moonshot Summit
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine hosted a Cancer Moonshot Summit on June 29 as part of U.S. Vice President Joe Biden’s nationwide effort to make more...
UHealth Part of Select Collaborative Using IBM’s Watson to Tackle Major Diseases
UHealth – the University of Miami Health System is part of a cognitive imaging collaborative that will be using IBM’s Watson to bring cognitive imaging into daily practice to help physicians address some of...
Sylvester Researchers Expand Firefighters Cancer Initiative with Renewed Funding
Surrounded by firefighters, advocates and lawmakers, researchers at Sylvester Comprehensive Cancer Center announced that they are extending the Firefighters Cancer Initiative started nearly one year ago. The goal of the partnership between South Florida’s...
Eye Color Determines Risk for Cancer
Clinical and epidemiological data have always pointed to eye cancer being more common among those individuals with light eye coloration and fair skin—however, the genetic mechanisms underlying disease development have been largely unknown. Now...
Two Genes May Help Predict Breast Cancer Survival
The activity of two genes may help predict certain breast cancer patients’ chances of survival and guide their treatment, British researchers report. “We have seen major strides in the treatment of breast cancer, but...
Cancer Link dedicated to finding ultimate cure for breast cancer
If you want to become involved in an effort that is truly saving lives, then join forces with Cancer Link, either as an individual committee member or as a community partner. Cancer Link is...
Nano beads fight liver cancer
A new type of Nano bead, a medical magnetic bead, may offer better treatment for some liver cancers. It’s called the LUMI bead and it lets doctors see in real time if the bead...
Curing childhood cancer will take a multi-pronged attack across many fronts
Over the past years, significant progress has been made in the fight against childhood cancer. Still, more than 15,000 young Americans under the age of 21 will be diagnosed with cancer this year, and...
Ado-trastuzumab emtansine effective for previously treated HER-2–positive metastatic breast cancer
Ado-trastuzumab emtansine may provide meaningful benefit to patients with HER-2–positive metastatic breast cancer who underwent prior treatment with trastuzumab and pertuzumab, according to retrospective study results. In 2013, the FDA approved ado-trastuzumab emtansine (Kadcyla,...
The Case of the Missing T-Cells
We talk a lot about the hardware that’s going to get us to Mars, but the most important things about human spaceflight is, well, humans! There’s a lot of research going into the impact...